# A Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma

> **NCT02787642** · PHASE1 · COMPLETED · sponsor: **Institut Bergonié** · enrollment: 41 (actual)

## Conditions studied

- Soft-tissue Sarcoma

## Interventions

- **DRUG:** Olaparib
- **RADIATION:** Concomitant Radiotherapy

## Key facts

- **NCT ID:** NCT02787642
- **Lead sponsor:** Institut Bergonié
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2021-10
- **Final completion:** 2022-05
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2026-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02787642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02787642, "A Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02787642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*